MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities,
short-term
$62,876K
Cash and cash
equivalents
$53,989K
Prepaid expenses and
other current assets
$5,387K
Total current assets
$122,252K
Other assets,
long-term
$350K
Restricted cash
$231K
Total assets
$122,833K
Total liabilities and
stockholders equity
$122,833K
Total stockholders
equity
$70,430K
Total liabilities
$52,403K
Accumulated deficit
-$446,462K
Additional paid-in capital
$516,803K
Total current
liabilities
$30,007K
Debt, long-term
$22,396K
Accumulated other
comprehensive income (loss)
$83K
Common stock, 0.0001
par value...
$6K
Accrued clinical trial
expenses
$10,616K
Accrued expenses and
other current...
$10,072K
Debt, short-term
$8,765K
Accounts payable
$554K
Back
Back
Balance Sheet
source: myfinsight.com
Acumen Pharmaceuticals, Inc. (ABOS)
Acumen Pharmaceuticals, Inc. (ABOS)